Potential utility of plasma p-tau and NfL as surrogate biomarkers for preventive clinical trials
View ORCID ProfilePâmela C. L Ferreira, View ORCID ProfileJoão Pedro Ferrari-Souza, View ORCID ProfileCécile Tissot, Bruna Bellaver, View ORCID ProfileDouglas T. Leffa, Firoza Z. Lussier, Guilherme Povala, Joseph Therriault, Andrea L. Benedet, Nicholas J. Ashton, Ann D. Cohen, Oscar L. Lopez, Dana L. Tudorascu, William E. Klunk, Jean-Paul Soucy, Serge Gauthier, Victor L. Villemagne, Henrik Zetterberg, Kaj Blennow, Pedro Rosa-Neto, Eduardo R Zimmer, View ORCID ProfileThomas K. Karikari, Tharick A. Pascoal, Alzheimer’s Disease Neuroimaging Initiative
doi: https://doi.org/10.1101/2022.08.17.22278853
Pâmela C. L Ferreira
1Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
João Pedro Ferrari-Souza
1Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
2Graduate Program in Biological Sciences: Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
Cécile Tissot
1Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
3Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer’s Disease Research Unit, Douglas Research Institute, Le Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l’Ouest-de-l’Île-de-Montréal
4Department of Neurology and Neurosurgery, Psychiatry and Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada
Bruna Bellaver
1Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
2Graduate Program in Biological Sciences: Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
Douglas T. Leffa
5ADHD Outpatient Program & Development Psychiatry Program, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil
Firoza Z. Lussier
1Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
Guilherme Povala
1Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
2Graduate Program in Biological Sciences: Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
Joseph Therriault
3Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer’s Disease Research Unit, Douglas Research Institute, Le Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l’Ouest-de-l’Île-de-Montréal
4Department of Neurology and Neurosurgery, Psychiatry and Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada
Andrea L. Benedet
6Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
7Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden
Nicholas J. Ashton
6Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
7Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden
8Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden
9Department of Old Age Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
Ann D. Cohen
1Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
Oscar L. Lopez
1Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
Dana L. Tudorascu
1Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
William E. Klunk
1Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
Jean-Paul Soucy
3Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer’s Disease Research Unit, Douglas Research Institute, Le Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l’Ouest-de-l’Île-de-Montréal
Serge Gauthier
4Department of Neurology and Neurosurgery, Psychiatry and Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada
Victor L. Villemagne
1Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
Henrik Zetterberg
6Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
7Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden
8Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden
10Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK
11UK Dementia Research Institute at UCL, London, UK
12Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China
Kaj Blennow
6Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
7Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden
Pedro Rosa-Neto
3Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer’s Disease Research Unit, Douglas Research Institute, Le Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l’Ouest-de-l’Île-de-Montréal
4Department of Neurology and Neurosurgery, Psychiatry and Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada
Eduardo R Zimmer
2Graduate Program in Biological Sciences: Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil
Thomas K. Karikari
1Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
6Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden
Tharick A. Pascoal
1Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA
- Supplemental Table 1[supplements/278853_file03.pdf]
Posted August 18, 2022.
Potential utility of plasma p-tau and NfL as surrogate biomarkers for preventive clinical trials
Pâmela C. L Ferreira, João Pedro Ferrari-Souza, Cécile Tissot, Bruna Bellaver, Douglas T. Leffa, Firoza Z. Lussier, Guilherme Povala, Joseph Therriault, Andrea L. Benedet, Nicholas J. Ashton, Ann D. Cohen, Oscar L. Lopez, Dana L. Tudorascu, William E. Klunk, Jean-Paul Soucy, Serge Gauthier, Victor L. Villemagne, Henrik Zetterberg, Kaj Blennow, Pedro Rosa-Neto, Eduardo R Zimmer, Thomas K. Karikari, Tharick A. Pascoal, Alzheimer’s Disease Neuroimaging Initiative
medRxiv 2022.08.17.22278853; doi: https://doi.org/10.1101/2022.08.17.22278853
Potential utility of plasma p-tau and NfL as surrogate biomarkers for preventive clinical trials
Pâmela C. L Ferreira, João Pedro Ferrari-Souza, Cécile Tissot, Bruna Bellaver, Douglas T. Leffa, Firoza Z. Lussier, Guilherme Povala, Joseph Therriault, Andrea L. Benedet, Nicholas J. Ashton, Ann D. Cohen, Oscar L. Lopez, Dana L. Tudorascu, William E. Klunk, Jean-Paul Soucy, Serge Gauthier, Victor L. Villemagne, Henrik Zetterberg, Kaj Blennow, Pedro Rosa-Neto, Eduardo R Zimmer, Thomas K. Karikari, Tharick A. Pascoal, Alzheimer’s Disease Neuroimaging Initiative
medRxiv 2022.08.17.22278853; doi: https://doi.org/10.1101/2022.08.17.22278853
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2931)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12734)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4578)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2914)
- Health Policy (1069)
- Hematology (388)
- HIV/AIDS (924)
- Medical Education (424)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4345)
- Nursing (236)
- Nutrition (638)
- Oncology (2266)
- Ophthalmology (645)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (500)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6932)
- Radiology and Imaging (1526)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (487)
- Toxicology (60)
- Transplantation (210)
- Urology (180)